Benefits of Breast Cancer Screening and Treatment on Mortality-Reference-Cited by-同舟云学术

Benefits of Breast Cancer Screening and Treatment on Mortality

Published:2024-01-16 Issue:3 Volume:331 Page:199
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Wheeler Stephanie B.¹²,Rocque Gabrielle³⁴,Basch Ethan¹²⁵⁶

Affiliation:

1. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

3. O’Neal Comprehensive Cancer Center, Birmingham, Alabama

4. Department of Medicine, Divisions of Hematology & Oncology and Gerontology, Geriatrics, & Palliative Care, University of Alabama at Birmingham

5. Division of Oncology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill

6. Associate Editor, JAMA

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2813902/jama_wheeler_2024_ed_230102_1704388782.4183.pdf

Reference6 articles.

1. Analysis of breast cancer mortality in the US—1975 to 2019.;Caswell-Jin;JAMA,2024

2. Pembrolizumab for early triple-negative breast cancer.;Schmid;N Engl J Med,2020

3. Sacituzumab govitecan in metastatic triple-negative breast cancer.;Bardia;N Engl J Med,2021

4. Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.;Zebrowska;Front Pharmacol,2023

5. Surveillance, Epidemiology, and End Results (SEER). Cancer Statistics, 2023. Accessed December 11, 2023. https://seer.cancer.gov/statfacts/html/breast.html

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients;Genes;2024-08-19

2. Exosomal microRNAs in lung cancer: a narrative review;Translational Cancer Research;2024-06

3. USPSTF Breast Cancer Screening Guidelines Do Not Go Far Enough;JAMA Oncology;2024-06-01

4. Evaluation of Tumor Control and Normal Tissue Complication Probabilities in Patients Receiving Comprehensive Nodal Irradiation for Left-Sided Breast Cancer;Current Oncology;2024-05-31

5. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction;Journal of Nanobiotechnology;2024-05-09